Table 2.
Study quality evaluation via the Newcastle-Ottawa Scale.
Study | Representativeness of the exposed cohort | Selection of the non-exposed cohort | Ascertainment of exposure | Outcome not present at baseline | Control for age and sex | Control for other confounding factors | Assessment of outcome | Enough long follow-up duration | Adequacy of follow-up of cohorts | Total |
---|---|---|---|---|---|---|---|---|---|---|
Lee 2012 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 |
Nielsen 2012 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 |
Choi 2013 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 7 |
Krane 2014 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 |
Hamilton 2014 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 |
Viers 2015 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 |
Kaffenberger 2015 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 |
Haddad 2015 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 |
McKay 2016 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 |
Nayan 2016 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 |
El-Refai 2017 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 6 |
Berquist 2017 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 |
Neumann 2019 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 |
Boegemann 2020 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 |
Heide 2020 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 |
Fiala 2021 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 |
Santoni 2022 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 |